S&P 500 7,718.60 −0.38%
Nasdaq 26,506.99 −0.29%
S&P/TSX 36,513.80 −0.33%
Apple 319.97 −2.51%
Nvidia 230.36 +0.84%
Microsoft 499.70 −2.04%
Shopify 200.76 −0.10%
Royal Bank 291.48 −0.30%
CAD/USD 0.7229 −0.32%
CLOSED · 16:05 ET
Market ClerkRecap
Sun Sep 6 · markets closed2 signals today321 insider buys this week · $404MCIRO short report next: Sep 15The week ahead
KS
INSIDER · KRYS · Krystal Biotech, Inc. · PRESIDENT, R&D

Krishnan Suma

Every open-market transaction filed under this name, Sep 4 to Sep 4.

Filings
13
0 buys · 13 sells
Bought
open market, at cost
Sold
$9M
includes scheduled sales
Buys since
no current price on file

Filings

SEC FORM 4 · OPEN MARKET
TradedTickerCompanyRoleTypeSharesPriceValueSince
Sep 4KRYSKrystal Biotech, Inc.President, R&DSell399$366.56$146K−2.3%
Sep 4KRYSKrystal Biotech, Inc.President, R&DSell826$365.41$302K−2.0%
Sep 4KRYSKrystal Biotech, Inc.President, R&DSell1,329$364.48$484K−1.7%
Sep 4KRYSKrystal Biotech, Inc.President, R&DSell565$363.34$205K−1.4%
Sep 4KRYSKrystal Biotech, Inc.President, R&DSell1,992$362.65$722K−1.2%
Sep 4KRYSKrystal Biotech, Inc.President, R&DSell1,242$361.61$449K−0.9%
Sep 4KRYSKrystal Biotech, Inc.President, R&DSell2,320$360.47$836K−0.6%
Sep 4KRYSKrystal Biotech, Inc.President, R&DSell3,392$359.39$1.2M−0.3%
Sep 4KRYSKrystal Biotech, Inc.President, R&DSell3,180$358.42$1.1M−0.1%
Sep 4KRYSKrystal Biotech, Inc.President, R&DSell3,962$357.57$1.4M+0.2%
Sep 4KRYSKrystal Biotech, Inc.President, R&DSell3,267$356.37$1.2M+0.5%
Sep 4KRYSKrystal Biotech, Inc.President, R&DSell2,006$355.57$713K+0.8%
Sep 4KRYSKrystal Biotech, Inc.President, R&DSell520$354.54$184K+1.0%

"Since" is the stock's move from the filed price to the latest quote on file, not a scored call. Open-market purchases and sales only; option exercises and grants are excluded.